06/12/2024 | Referral: Metamizole-containing medicinal products - referral | Updated |
06/12/2024 | Event: Q&A Clinic on post-authorisation procedure management in IRIS (2) | New |
06/12/2024 | Page: Quality of medicines questions and answers: Part 1 | Updated |
06/12/2024 | Event: European Commission/EMA meeting with stakeholders on Translarna (ataluren) | New |
06/12/2024 | News: Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 December 2024 | New |
06/12/2024 | Medicine: Icthiovac ERM | New |
06/12/2024 | Medicine: Poulvac Procerta HVT-IBD-ND | New |
06/12/2024 | Medicine: Tolfenamic acid VMD | New |
06/12/2024 | Document: European Medicines Agency’s data protection notice regarding the experts database and the handling of competing interests of scientific committees’ members and experts | Updated |
06/12/2024 | Medicine: Lixiana | Updated |
06/12/2024 | Medicine: Votubia | Updated |
06/12/2024 | Page: Artificial intelligence | Updated |
06/12/2024 | Document: Draft qualification opinion for artificial intelligence-based measurement of non-alcoholic steatohepatitis histology in liver biopsies to determine disease activity in NASH/MASH clinical trials | New |
06/12/2024 | Event: Q&A Clinic on post-authorisation procedure management in IRIS (1) | New |
06/12/2024 | Medicine: Bemrist Breezhaler | Updated |
06/12/2024 | Medicine: Atectura Breezhaler | Updated |
06/12/2024 | Referral: Finasteride- and dutasteride-containing medicinal products - referral | Updated |
05/12/2024 | Medicine: Tafinlar | Updated |
05/12/2024 | Event: 2024 annual workshop of the European network of paediatric research at EMA (Enpr-EMA) | Updated |
05/12/2024 | Event: 2024 annual meeting of the members and Coordinating Group of the European network of paediatric research at the EMA (Enpr-EMA) | New |
05/12/2024 | Medicine: Pregabalin Viatris (previously Pregabalin Mylan) | Updated |
05/12/2024 | Document: New product information wording – Extracts from PRAC recommendations on signals adopted at the 28-31 October 2024 PRAC | Updated |
05/12/2024 | DHPC: Ibandronic acid Accord - direct healthcare professional communication (DHPC) | New |
05/12/2024 | Medicine: Mekinist | Updated |
05/12/2024 | Medicine: Alli (previously Orlistat GSK) | Updated |
05/12/2024 | Medicine: Hemgenix | Updated |
05/12/2024 | Medicine: Vantavo (previously Alendronate sodium and colecalciferol, MSD) | Updated |
05/12/2024 | Medicine: Adrovance | Updated |
05/12/2024 | Medicine: Esperoct | Updated |
05/12/2024 | Medicine: Pyzchiva | Updated |
05/12/2024 | Medicine: Nexium Control | Updated |
05/12/2024 | Medicine: Spexotras | Updated |
05/12/2024 | Medicine: Baqsimi | Updated |
05/12/2024 | Medicine: Posaconazole Accord | Updated |
05/12/2024 | Page: Clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) - Scientific guideline | Updated |
05/12/2024 | Event: EMA workshop on the challenges in drug development, regulation and clinical practice in hemoglobinopathies | Updated |
05/12/2024 | Event: European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties meeting with all eligible organisations - 2024 | Updated |
05/12/2024 | Medicine: Supemtek | Updated |
05/12/2024 | Medicine: Arsenic trioxide Accord | Updated |
05/12/2024 | Document: Guidance for applicants seeking scientific support and advice on traditional herbal medicinal products | Updated |
05/12/2024 | Medicine: Ovaleap | Updated |
05/12/2024 | Medicine: Moventig | Updated |
05/12/2024 | Medicine: Theralugand | Updated |
05/12/2024 | Medicine: Fosavance | Updated |
05/12/2024 | Medicine: Kevzara | Updated |
05/12/2024 | Event: Submission of Manufacturers, Manufacturing Business Operations (MBOs) and structured pack size data to Product Management Service (PMS) | Updated |
05/12/2024 | Event: UPD refresher webinar for marketing authorisation holders on volume of sales submission | Updated |
05/12/2024 | Event: 19th industry stakeholder platform - operation of European Union (EU) pharmacovigilance | Updated |
05/12/2024 | Document: Three-year work plan for the Quality Drafting Group (QDG) of the Committee on Herbal Medicinal Products (HMPC) | Updated |
05/12/2024 | Document: Data protection notice for the Experts Management Tool and the handling of competing interests | New |
05/12/2024 | Medicine: Jcovden (previously COVID-19 Vaccine Janssen) | Updated |
05/12/2024 | Document: Jcovden : Periodic safety update report assessment 25 February 2023 to 24 February 2024 | New |
04/12/2024 | Document: Guidance on the electronic submission of information on investigational medicinal products for human use in the Extended EudraVigilance medicinal product dictionary (XEVMPD) | Updated |
04/12/2024 | Medicine: Erleada | Updated |
04/12/2024 | Event: Seventh European Medicines Agency (EMA) and EFPIA bilateral meeting | Updated |
04/12/2024 | Medicine: Advate | Updated |
04/12/2024 | Medicine: Kovaltry | Updated |
04/12/2024 | Medicine: Duloxetine Viatris (previously Duloxetine Mylan) | Updated |
04/12/2024 | Page: How to pay | Updated |
04/12/2024 | Document: How to pay fees and charges levied by EMA: Guidance to marketing authorisation holders and applicants | New |
04/12/2024 | PSUSA: PSUSA/00000772/202404 - periodic safety update report single assessment | New |
04/12/2024 | Medicine: Bimervax | Updated |
04/12/2024 | Document: Bimervax: Periodic safety update report assessment 30 March 2023 to 29 September 2023 | New |
04/12/2024 | Document: EVVet3 EVWeb Production - Release notes | Updated |
04/12/2024 | Document: Record of data processing activity relating to Security Access Control System | Updated |
04/12/2024 | Document: European Medicines Agency’s data protection notice for the operation of the Security Access Control System | Updated |
04/12/2024 | Event: Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party | Updated |
04/12/2024 | Document: Agenda - Medicine Shortages (SPOC) Working Party 5 December 2024 | New |
04/12/2024 | Page: Clinical requirements for non replacement therapy in haemophilia A and B - Scientific guideline | Updated |
04/12/2024 | Document: Medicine shortage mitigation plan - template | Updated |
04/12/2024 | Document: Medicine shortage prevention plan - template | Updated |
04/12/2024 | Medicine: Menveo | Updated |
04/12/2024 | Medicine: Scintimun | Updated |
04/12/2024 | Medicine: Ocaliva | Updated |
04/12/2024 | Document: Scintimun-H-C-PSUSA-00000385-202401 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation | New |
04/12/2024 | Page: Submission deadlines for orphan designations | Updated |
04/12/2024 | Document: Deadlines for submission of applications for orphan medicinal product designation to the EMA and corresponding COMP timetable for valid applications - 2024-2025 | Updated |
03/12/2024 | Medicine: Bevespi Aerosphere | Updated |
03/12/2024 | Document: List of substances and products subject to worksharing for signal management | Updated |
03/12/2024 | Medicine: Tauvid | Updated |
03/12/2024 | Medicine: Zolgensma | Updated |
03/12/2024 | Medicine: Enhertu | Updated |
03/12/2024 | Document: Pediatric Cluster Terms of Reference | Updated |
03/12/2024 | Medicine: Fluad | Updated |
03/12/2024 | Medicine: Celsentri | Updated |
03/12/2024 | Medicine: Xolair | Updated |
03/12/2024 | Medicine: Casgevy | Updated |
03/12/2024 | Referral: Ocaliva - referral | Updated |
03/12/2024 | Medicine: Tasigna | Updated |
03/12/2024 | Event: Translating innovation into access for ATMPs: third EU-Innovation network multi-stakeholder meeting | Updated |
03/12/2024 | Orphan: EU/3/23/2828 - orphan designation for treatment of transthyretin-mediated amyloidosis | Updated |
03/12/2024 | Medicine: Briviact (in Italy: Nubriveo) | Updated |
03/12/2024 | Document: Briviact-H-C-PSUSA-00010447-202401 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation | New |
03/12/2024 | Event: EU NTC ten year anniversary event | Updated |
03/12/2024 | Document: Report - EU NTC ten year anniversary event | New |
03/12/2024 | Event: Quarterly system demo - Q4 2024 | Updated |
03/12/2024 | Medicine: Kimmtrak | Updated |
03/12/2024 | Page: Clinical evaluation of medicinal products used in weight control - Scientific guideline | Updated |
03/12/2024 | Document: Concept paper on the need for revision of the addendum on weight control in children to the guideline on clinical evaluation of medicinal products used in weight control | New |
03/12/2024 | Event: Committee for Medicinal Products for Veterinary Use (CVMP): 3-5 December 2024 | Updated |
03/12/2024 | Document: Agenda of the COMP meeting 3-5 December 2024 | New |
03/12/2024 | Document: EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 2: Format for the electronic submission of veterinary medicinal product information | Updated |
03/12/2024 | Medicine: Lumykras | Updated |
03/12/2024 | Document: Lumykras : EPAR - Risk management plan | New |
03/12/2024 | Document: Agenda of the CVMP meeting 3-5 December 2024 | New |
03/12/2024 | Document: Record of data processing activity for the Experts Management Tool and the handling of competing interests | Updated |
03/12/2024 | Document: Expected publication dates of PRAC recommendations on safety signals | Updated |
03/12/2024 | DHPC: Metamizole - direct healthcare professional communication (DHPC) | New |
03/12/2024 | Orphan: EU/3/16/1752 - orphan designation for treatment of haemophilia A | Updated |
02/12/2024 | Medicine: Eribulin Baxter | Updated |
02/12/2024 | Medicine: Tavlesse | Updated |
02/12/2024 | PSUSA: PSUSA/00002204/202404 - periodic safety update report single assessment | New |
02/12/2024 | Medicine: Dabigatran etexilate Teva (previously Dabigatran etexilate Leon Farma) | Updated |
02/12/2024 | Medicine: Nustendi | Updated |
02/12/2024 | Medicine: Nilemdo | Updated |
02/12/2024 | Medicine: Cablivi | Updated |
02/12/2024 | Medicine: Prevexxion RN+HVT+IBD | Updated |
02/12/2024 | Page: National competent authorities (human) | Updated |
02/12/2024 | Medicine: Metacam | Updated |
02/12/2024 | Medicine: Sancuso | Updated |
02/12/2024 | Medicine: Frontpro (previously known as Afoxolaner Merial) | Updated |
02/12/2024 | Medicine: Cerezyme | Updated |
02/12/2024 | Medicine: Dupixent | Updated |
02/12/2024 | Event: Committee for Advanced Therapies (CAT): 4-6 December 2024 | Updated |
02/12/2024 | Medicine: Fabhalta | Updated |
02/12/2024 | Document: Agenda of the CAT meeting 4-6 December 2024 | New |
02/12/2024 | Document: Abbreviations used in EMA scientific committees and CMD documents, and in relation to EMA’s regulatory activities | Updated |
02/12/2024 | Document: QRD Appendix I - Adverse event (PhV) MSs reporting details | Updated |
02/12/2024 | Event: Paediatric Committee (PDCO): 15-18 October 2024 | Updated |
02/12/2024 | Document: Minutes - PDCO minutes of the 15-18 October 2024 meeting | New |
02/12/2024 | Event: Thirteenth meeting of the industry stakeholder platform on research and development support | New |